ALFA FinderBSE filing, NSE: VENMAX. Summary written from the filing by ALFA Finder's alert engine.
Venmax Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹14.32
- Market cap
- ₹12.58 Cr
- Revenue (annual)
- ₹8.02 Cr
- Net profit (annual)
- ₹0.25 Cr
- P/E (TTM)
- 44.9×Sector 43.8×
- Promoter holding
- 10.46%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venmax Drugs & Pharmaceuticals Ltd
All →Venmax Drugs & Pharmaceuticals Q2 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% QoQ
Venmax Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹5.3 Cr (+307.7% YoY) and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Venmax Drugs & Pharmaceuticals Board Meeting Date
Venmax Drugs and Pharmaceuticals will hold a board meeting on November 12, 2026 to consider unaudited standalone results for the quarter ended September 30, 2026. The trading window stays closed until November 14, 2026.
Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs' shareholders met on 24 October 2026 under an NCLT order to approve an amalgamation with Hatri Pharma. Voting results await the scrutinizer's report.
Venmax Drugs & Pharmaceuticals Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Venmax Drugs & Pharmaceuticals Annual General Meeting
Venmax Drugs and Pharmaceuticals held its 37th Annual General Meeting on September 26, 2026. Shareholders considered the financial statements and various directorship appointments.
Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs and Pharmaceuticals Limited announced an NCLT-convened meeting of equity shareholders on October 24, 2026, to consider the proposed merger with Hatri Pharma Private Limited.
Other other announcement announcements
All →TECIL Chemicals & Hydro Power Other Announcement
TECIL Chemicals appointed HB and Associates as secretarial auditors after JMACS resigned. The five-year term is subject to shareholder approval at the AGM.
- Execution
- FY 2026-27 to FY 2030-31
Kuber Udyog Other Announcement
RBI cancelled Kuber Udyog's NBFC Certificate of Registration at its voluntary request. The company had already stopped NBFC activities, so no material impact is expected.
Niraj Ispat Industries Other Announcement
Niraj Ispat is exempt from Reg 23(9) related party disclosures for half year ended 30 September 2026. The exemption follows low paid-up capital and net worth.
D-Link (India) Other Announcement
KFin Technologies, D-Link's registrar, will move its corporate office from December 1, 2026. Shareholders should send RTA-related correspondence to the new address.
Mukand Other Announcement
Registrar KFIN Technologies will shift its corporate office from December 1, 2026. Shareholders should redirect correspondence to the new address.
Pushpa Jewellers Other Announcement
Pushpa Jewellers filed a monitoring agency report on IPO proceeds for the quarter ended September 2026. It reports no deviation from stated issue objects.